These two authors contributed equally to this manuscript.
The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils – implications for asthma
Version of Record online: 18 JAN 2013
© 2013 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd
Volume 68, Issue 3, pages 304–311, March 2013
How to Cite
The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils – implications for asthma. Allergy 2013; 68: 304–311., , , .
Edited by: Hans-Uwe Simon
- Issue online: 8 FEB 2013
- Version of Record online: 18 JAN 2013
- Manuscript Accepted: 28 OCT 2012
- Swedish Research Council. Grant Numbers: 20854, 10350
- Swedish Strategic Foundation (SSF)
- Swedish Cancer Society
- Thorsten & Ragnar Söderberg's Foundation
- Swedish Heart Lung Foundation
- Stockholm County Council. Grant Number: 20090136
- Karolinska Institutet
Figure S1. LL-37 mediates LTB4 release from eosinophils (n = 4).
Figure S2. A FPR-2 receptor agonist peptide WKYMVm (Wp), similarly as LL-37, induced cys-LT release from eosinophils (n = 3).
Figure S3. Densitometry analysis of LL-37-induced p-cPLA2 (A) and cPLA2 (B) expression normalized to GAPDH (n = 3).
Figure S4. Densitometry analysis of LL-37-stimulated p-ERK1 and p-ERK2 expression normalized to ERK1 and ERK2 (n = 4).
Figure S5. Densitometry analysis of the effect of PD-98059 on p-cPLA2 expression normalized to cPLA2 (n = 4).
Figure S6. LL-37 induces ECP release from eosinophils (n = 4).
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.